Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Operating Expenses (2014 - 2026)

Updated

Zevra Therapeutics' Operating Expenses was $21.05 million in Q2 2026, down 13.1% from $24.22 million a year earlier and down 16.4% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Operating Expenses (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Zevra Therapeutics' Operating Expenses was $89.56 million through Jun 30, 2026, down 9.2% year-over-year; for FY2025, it came in at $90.36 million, down 6.8% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 36.7% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $96.96 million in FY2024 (+30.8%), $74.12 million in FY2023 (+40.6%), $52.73 million in FY2022 (+152.0%) and $20.92 million in FY2021 (+10.7%).
  • Quarterly Operating Expenses has moved between $4.19 million (Q3 2021) and $27.15 million (Q3 2024) over five years.
  • Compared with a year earlier, Operating Expenses was higher in four of the last eight quarters, with growth averaging 2.2%.
  • The best year-over-year quarter for Operating Expenses over five years was Q2 2022 (growth of 323.6%); the worst was Q2 2023 (a decline of 46.1%).
  • Per Business Quant data, ZVRA's Operating Expenses in the three quarters before Q2 2026 was $25.18 million (Q1 2026), $22.97 million (Q4 2025) and $20.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Zevra Therapeutics 650.98 Mn -161.73 Mn 38.18 Mn 21.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.05 Mn
Mar 31, 2026 25.18 Mn
Dec 31, 2025 22.97 Mn
Sep 30, 2025 20.37 Mn
Jun 30, 2025 24.22 Mn
Mar 31, 2025 22.80 Mn
Dec 31, 2024 24.48 Mn
Sep 30, 2024 27.15 Mn
Jun 30, 2024 23.13 Mn
Mar 31, 2024 22.21 Mn
Dec 31, 2023 26.08 Mn
Sep 30, 2023 18.12 Mn
Jun 30, 2023 14.05 Mn
Mar 31, 2023 15.88 Mn
Dec 31, 2022 11.34 Mn
Sep 30, 2022 9.50 Mn
Jun 30, 2022 26.07 Mn
Mar 31, 2022 5.82 Mn
Dec 31, 2021 5.42 Mn
Sep 30, 2021 4.19 Mn
API Access

Zevra Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY